Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Daprodustat in Chinese Hemodialysis-dependent Subjects with Anemia Associated with CKD
NCT07300111Phase 3Not yet recruiting
- Sponsor
- Qilu Pharmaceutical
- Start
- Dec 2025
- Primary completion
- May 2027
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of daprodustat in anemia of chronic kidney disease, sponsored by Qilu Pharmaceutical. Planned start Dec 2025; status: not yet recruiting.
02
Drugs
daprodustat
03
Conditions
anemia of chronic kidney disease
Beyond the preview
Go deeper on NCT07300111.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07300111.